Publication: The LancetDesign: Open-label, single-arm study of 157 patients who had undergone a median of six previous lines of therapy and who received at least one dose of teclistamab; 40 patients received the recommended phase II dose of teclistamabResults: Of the 40 receiving the phase II dose, 58% achieved a very good partial response or […]
According to the SUSTAIN FORTE study presented online in The Lancet Diabetes & Endocrinology, doubling the dose of semaglutide (Ozempic) might be a helpful option for people not achieving glycemic goals. Still, some researchers aren’t convinced this is a sound strategy – “statistically significant but barely clinically relevant” — suggesting opting for another agent when […]
In this commentary from The Lancet, the author suggests that COVID-19 is not a pandemic, but a syndemic, which is defined as a set of linked health problems involving two or more afflictions, interacting synergistically, and contributing to excess burden of disease in a population. The syndemic approach reveals biological and social interactions that are […]
In this editorial from The Lancet, the authors dissect the 160,000 new cases reported each day worldwide since June 25 and how these numbers illustrate a worrying pattern of the world facing a worsening multipolar pandemic despite the nuanced subnational picture level.